LONE TREE, Colo., Jan. 8, 2026 /PRNewswire/ -- Cochlear, the global leader in implantable hearing solutions, is proud to announce that the groundbreaking Nucleus® Nexa® System is now available to ...

LONE TREE, Colo., July 8, 2025 /PRNewswire/ -- Cochlear Limited (ASX: COH), the global leader in implantable hearing solutions, today announced the U.S Food and Drug Administration (FDA) approval of ...

The new Cochlear™ Nucleus® Nexa® System is the first and only hearing implant featuring internal memory and upgradeable firmware. Approximately 63 million people in India suffer from significant ...

Hearing is one of those things most people never think about until it’s gone. For millions living with severe to profound hearing loss, a cochlear implant isn’t just a device. It’s a way back to ...

Cochlear Ltd. heard good news from the U.S. FDA, as the agency approved its next-generation cochlear implant, the Nucleus Nexa System, the first smart cochlear implant system. Cochlear expects to ...

The Cochlear Ltd (ASX: COH) share price is in focus today after the hearing implant leader posted a modest 1% lift in sales revenue to $1,176 million for the half year ended December 2025, but ...

Mumbai (Maharashtra) [India], March 2: Cochlear, the global leader in implantable hearing solutions, today launched the Cochlear Nucleus Nexa System - the world's first and only smart cochlear implant ...